Baxter International (NYSE:BAX) Director Carole Shapazian unloaded 5,680 shares of the stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $75.28, for a total value of $427,590.40. Following the transaction, the director now directly owns 5,146 shares in the company, valued at approximately $387,391. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
BAX has been the subject of a number of recent research reports. Analysts at Ned Davis Research upgraded shares of Baxter International from a “neutral” rating to a “buy” rating in a research note on Monday, April 28th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Baxter International in a research note on Monday, April 21st. They now have a $76.00 price target on the stock. Finally, analysts at Sanford C. Bernstein raised their price target on shares of Baxter International from $78.00 to $89.00 in a research note on Friday, March 28th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $78.23.
Baxter International (NYSE:BAX) traded up 0.16% on Tuesday, hitting $74.63. The stock had a trading volume of 338,198 shares. Baxter International has a 52 week low of $62.80 and a 52 week high of $75.68. The stock’s 50-day moving average is $71. and its 200-day moving average is $68.91. The company has a market cap of $40.538 billion and a price-to-earnings ratio of 20.30. Baxter International also was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 9,612,348 shares, a decline of 23.7% from the March 31st total of 12,604,179 shares. Approximately 1.8% of the shares of the stock are short sold. Based on an average trading volume of 3,041,190 shares, the days-to-cover ratio is presently 3.2 days.
Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, April 17th. The company reported $1.19 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.09 by $0.10. The company had revenue of $3.95 billion for the quarter, compared to the consensus estimate of $3.88 billion. During the same quarter last year, the company posted $1.05 earnings per share. Baxter International’s revenue was up 14.6% compared to the same quarter last year. Analysts expect that Baxter International will post $5.13 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, July 1st. Shareholders of record on Friday, June 6th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.79%.
Baxter International Inc (NYSE:BAX) is a global, diversified healthcare company.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.